Canada markets open in 4 hours 26 minutes

Esperion Therapeutics, Inc. (ESPR)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
1.9500+0.0800 (+4.28%)
At close: 04:00PM EDT
1.9300 -0.02 (-1.03%)
After hours: 06:22PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 368.38M
Enterprise Value 552.31M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)1.72
Price/Book (mrq)74.89
Enterprise Value/Revenue 4.75
Enterprise Value/EBITDA -3.68

Trading Information

Stock Price History

Beta (5Y Monthly) 0.82
52-Week Change 359.84%
S&P500 52-Week Change 320.07%
52 Week High 33.4000
52 Week Low 30.7000
50-Day Moving Average 32.4596
200-Day Moving Average 31.7778

Share Statistics

Avg Vol (3 month) 36.28M
Avg Vol (10 day) 36.91M
Shares Outstanding 5189.4M
Implied Shares Outstanding 6189.4M
Float 8184.03M
% Held by Insiders 10.45%
% Held by Institutions 139.19%
Shares Short (Mar 28, 2024) 419.92M
Short Ratio (Mar 28, 2024) 43.13
Short % of Float (Mar 28, 2024) 412.02%
Short % of Shares Outstanding (Mar 28, 2024) 410.77%
Shares Short (prior month Feb 29, 2024) 416.95M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Dec 31, 2023


Profit Margin -179.87%
Operating Margin (ttm)-131.37%

Management Effectiveness

Return on Assets (ttm)-42.86%
Return on Equity (ttm)N/A

Income Statement

Revenue (ttm)116.33M
Revenue Per Share (ttm)1.13
Quarterly Revenue Growth (yoy)71.40%
Gross Profit (ttm)N/A
EBITDA -155.4M
Net Income Avi to Common (ttm)-209.25M
Diluted EPS (ttm)-2.0300
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)82.25M
Total Cash Per Share (mrq)0.44
Total Debt (mrq)540.95M
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)1.29
Book Value Per Share (mrq)-3.85

Cash Flow Statement

Operating Cash Flow (ttm)-135.49M
Levered Free Cash Flow (ttm)-107.14M